glp-1 kidney disease Frontiers GLP-1 receptor agonists and next-generation

Some observational data suggest that weight loss achieved through any meansincluding GLP-1 medications, bariatric surgery, or lifestyle modificationmay have modest effects on thyroid function tests in individuals with obesity

This may not be a typical side effect but it is still something to consider for anyone thinking of buying this supplement

Broad access to an oral GLP-1 changes how obesity care can be integrated into everyday treatment pathways

Ralph Pisano, president of Goodroot affiliate company Nuwae, told Fierce Healthcare that the path toward coverage for payers might be similar to what went on with Botox, Viagra and medications for hepatitis C, except that advances in social media and its ubiquitousness speed up the patient demand and payer pushback dynamic